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Abstract
Background Regenerative gene therapy using viral vectors enables
transduced cells to express bioactive factors in vivo. Viral delivery with spatial
control can enhance transduction efficiency and may limit systemic infection.
Consequently, we tethered biotinylated adenovirus via interactions with
avidin on chitosan surfaces to gain robust control for in situ transduction.
Methods Avidin was either directly conjugated to chitosan (virus–biotin–
avidin-material; VBAM) or indirectly docked on biotinylated chitosan
surfaces (virus–biotin–avidin–biotin-material; VBABM) to tether biotinylated
adenovirus. Enzyme-linked immunosorbent assay (ELISA) and spectroscopic
analysis were performed to demonstrate the binding profiles. Biotin-
alkaline phosphatase and biotinylated adenovirus were used as different
sized particles to evaluate binding efficiencies and were compared by the
Sips isotherm adsorption method. Scanning electron microscopy (SEM)
examination illustrated virus distribution, and the transduction efficiency
was determined by in vitro cell transduction.
Results ELISA and spectroscopic analysis both demonstrated that the VBAM
system led to multilayer avidin formation on biomaterial surfaces, whereas
VBABM formed a monolayer of avidin. Sips isotherm adsorption indicated that
the VBAM method increased heterogeneity and steric hindrance of binding
sites. By contrast, the VBABM method docked avidin on chitosan surfaces
and orientated the binding sites to facilitate ligand binding. In addition, SEM
images illustrated that the VBABM method led to more even viral distribution.
In vitro cell infection experiments also demonstrated that the VBABM system
enhanced virus immobilization and thus improved cell transduction efficiency
over the VBAM system.
Conclusions The VBABM strategy is a superior method for in situ
transduction from biomaterials. This strategy could be adapted for use with a
variety of biomaterials as well as viral vectors, and thus may be an alternative
method for in vivo regenerative gene therapy. Copyright  2008 John Wiley
& Sons, Ltd.
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Introduction
Regenerative gene therapy by viral vectors can transduce cells to sustainedly
and stably express bioactive factors in vivo. Several viral delivery methods
have been developed for regenerative gene therapy. Bolus delivery by direct
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injection or inhalation is the easiest viral delivery method.
However, high dosages are necessary for therapeutic
effects because the virus may diffuse from the area
of injection, which may limit the regional effectiveness
and induce an immune response [1–4]. In addition,
the poor spatial control in bolus delivery may cause
unintended systemic infection [5]. Polymeric release is
an improved method that incorporates viral vectors in a
polymer matrix to control release by polymer degradation
[6]. This method permits the sustained release of the
virus to reduce viral immunogenicity and limit virus
degradation [6,7]. Unfortunately, because the virus is
not easily localized at the desired therapeutic target site
using this method, unwanted transduction at distant sites
may result in unanticipated consequences [8].
Substrate-mediated viral delivery is an alternative
approach that functions by complexing virus in or on a
biomaterial that also serves as a substrate for cell adhesion
[8,9]. Using this strategy, lyophilized viral vectors within
scaffolds can improve transduction efficiency, and thus
the dose of virus administrated can be reduced [10].
However, the diffusion of lyophilized virus from a
material surface is still unavoidable in this method, and
therefore spatial control is limited. Because viral vectors
immobilized on a biomaterial scaffold can transduce cells
in situ to reduce possible risks during in vivo application,
we exploited this strategy to gain robust control of cell
transduction from chitosan as a test material for the long
term goal of regenerative gene therapy.
Chitosan is a biodegradable polysaccharide derived
from crustacean shells [11]. The nontoxic and tissue
compatible properties of chitosan support its use as
a biomaterial for pharmaceutical and drug delivery
research [12,13]. In addition, chitosan has a hydrophilic
surface that may promote cell adhesion, proliferation,
and differentiation, and thus is broadly used as scaffold
material [14,15]. Furthermore, chitosan is synthesized by
chitin deacetylation due to its ambient amines, and can
be easily modified [16]. Therefore, we used chitosan as
a carrier with its active functional groups to immobilize
adenovirus on its surface and investigated its potential to
effectively deliver bioactive virus.
The binding forces involved in directly conjugating
a virus on a biomaterial surface may be too strong
to allow for the efficient release of virus for cell
internalization. Therefore, bioconjugation mediated by
noncovalent bonding should be a more effective method
of immobilizing viral particles on material surfaces
for in situ transduction. Virus can be immobilized by
antibody binding to localize gene expression on substrates
and avoid diffusion for in vivo transduction [17–19].
However, because an antibody is specific to an antigen,
different viral vectors would need to be captured by
different antibodies. In addition, because the titer of
antibody is highly affected by the host animal, a stable
source of antibody may be a problem. Furthermore,
immunization is expensive and time consuming. These
drawbacks make antibody immobilization difficult to
apply as a universal viral delivery method for clinical
application.
The biotin–avidin interaction is known to be the
strongest noncovalent bond, and this system has been
used for biotechnology applications [20]. The molecules
are commercially available and can be conjugated with
different materials. For example, chitosan has been
successfully biotinylated for enzyme immobilization as
bioprobes [21], and adenovirus biotinylation has been
applied to cell targeting and virus purification methods
[22]. In addition, biotinylated virus has been immobilized
on avidin coated culture plates for in situ infection [23].
However, protein coating by physical adsorption may be
less stable in in vivo environments [24].
Consequently, two different avidin immobilization
strategies on material surfaces were developed for
this study. Avidin was either directly conjugated
to chitosan (virus–biotin–avidin-material; VBAM) or
indirectly docked on biotinylated chitosan surfaces
(virus–biotin–avidin–biotin-material; VBABM) to tether
biotinylated adenovirus. By a range of experimental anal-
yses, we determined an effective and universal viral




Adenovirus encoding the β-galactosidase gene and
localization sequence (AdLacZ) was prepared by the
Vector Core, University of Michigan. This adenovirus
was biotinylated by sulfosuccinimidyl-6-[biotinamido]
hexanoate (SulfoNHS-LC-Biotin) (Pierce, Rockford, IL,
USA) which was dissolved in phosphate-buffered saline
(PBS; Pierce) before being reacted with adenovirus. The
conjugation reaction was performed at 4 ◦C for 2 h, and
then quenched by an equal volume 1M glycin (Sigma-
Aldrich, St Louis, MO, USA) in PBS. Ultrafiltration was
applied using centricon filters (50 kDa MWCO; Millipore,
Billerica, MA, USA) to remove unreacted biotin. The
biotinylated virus was sterilized by passing through a
0.2 µm syringe filter (Nalgene, Rochester, NY, USA).
To determine an appropriate concentration of
SulfoNHS-LC-Biotin for virus biotinylation, an avidin con-
jugated alkaline phosphatase (avidin-AP; MP Biomedicals,
Aurora, OH, USA) sandwich enzyme-linked immunosor-
bent assay (ELISA) was used to detect biotin on viral sur-
faces: Goat anti-adenovirus antibody (1 µg/well) (Abcam,
Cambridge, MA, USA) was coated on 96-well plates (Cor-
ing, Lowell, MA, USA) at 4 ◦C overnight, which was then
blocked with 1% bovine serum albumin (BSA; Roach, Indi-
anapolis, IN, USA) in PBS. Biotinylated virus was added
100 µl/well and incubated at room temperature for 1 h,
and the plates were washed with 0.05% Tween-20 in
PBS (PBST; Teknova, Hollister, CA, USA). Subsequently,
avidin-AP was added to label the biotin on the plate for
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1 h. After three washes in PBST, substrate p-nitrophenyl
phosphate (PNPP; Pierce) was added for 20 min, and
enzyme activity was detected by optical density at 405 nm
(OD405).
The number of biotin molecules per adenovirus was
determined by a 2-(4′-hydroxyazobenzene) benzoic acid
(HABA; Pierce) assay: 6 µmol of HABA was added to 5 mg
of avidin in 10 ml of PBS to prepare the HABA/avidin
solution. The solution (0.9 ml) was transferred by pipette
into a 1 ml cuvette to read spectrophotometrically
at OD500 (Beckman Coulter, Fullerton, CA, USA).
Biotinylated virus (0.1 ml) was then added and mixed
in the cuvette to read OD500. HABA had an absorption
wavelength of 500 nm when added to avidin. However,
this absorption decreased proportionally when biotin was
added. This was because the biotin displaced the HABA
dye due to its higher affinity for avidin. Therefore, the








where OD500 = OD500 nm of HABA/avidin × 0.9 −
OD500 nm of HABA/avidin/biotintinylated virus.
To determine whether biotinylation affected the
bioactivity of adenovirus, the fibroblast cell line C4
(ATCC, Manassas, VA, USA) was cultured in alpha-
minimal essential medium (Gibco, Carlsbad, CA, USA)
containing 10% fetal bovine serum (Gibco) and penicillin
(100 units/ml)–streptomycin (100 mg/ml) (Gibco) at a
density of 5 × 104 cells/well in 24-well culture plates
(Coring) for 1 day. Subsequently, AdLacZ (with or
without biotinylation) was added to the culture wells
for 48 h of infection. The transduction efficiencies of
each group were determined by the expression of
β-galactosidase, which was detected using a sandwich
ELISA kit (Roach).
Chitosan film preparation
Chitosan with molecular weight in the range 100–
300 kDa (Acros, Geel, Belgium) was dissolved in 0.5 M
acetic acid for a final concentration of 1.5%. After melting
at 60 ◦C overnight, the chitosan solution was filtered
through a 0.8-µm membrane. The chitosan solution
(1 ml/well) was placed into 24-well culture plates that
were then incubated at 80 ◦C overnight to evaporate the
acetic acid solvent. Each well was neutralized in 0.3 M
NaOH for 30 min and was then washed with PBS.
Avidin conjugation
Avidin (Pierce) in PBS was placed in chitosan-coated wells
(0.25 ml/well). Glutaraldehyde (Acros), the homobifunc-
tional crosslinker for bioconjugation, was also diluted in
PBS then added at 0.25 ml/well. After 2 h, the wells were
washed with PBS to remove nonreactive reagent. Glycine
(2 M) in PBS was used to quench nonreactive crosslinker
on the plate for 30 min. Finally, the plates were washed
with 70% ethanol for sterilization.
For the VBABM method, avidin was indirectly docked
on a biotinylated surface before immobilizing biotinylated
molecules. Avidin was dissolved in PBS and placed at
0.25 ml/well for 2 h of incubation at room temperature
and then washed with PBS to remove excess avidin.
The surface avidin was evaluated by a biotin conjugated
alkaline phosphatase (biotin-AP; Pierce) assay: After
blocking with 1% BSA-PBS, biotin-AP was diluted in PBS
(12 ng/ml) and added to the plates (0.25 ml/well) for
1 h, and was developed by 0.2 ml of PNPP substrate




Biotin; Pierce) was dissolved in PBS and placed in
chitosan-coated wells at 0.25 ml/well. Glutaraldehyde
was also diluted in PBS and then added at 0.25 ml/well.
After 2 h of incubation at room temperature, the wells
were washed with PBS to remove nonreactive regent.
Quenching by glycine solution and sterilizing by 70%
ethanol were performed as previously described.
Surface biotin was quantified by avidin-AP. After
blocking with 1% BSA-PBS, avidin-AP was diluted in PBS
(0.112 µg/ml) and added at 0.25 ml/well to incubate
for 1 h, and was then detected by substrate PNPP, as
previously described.
Ultraviolet (UV) detection for avidin
immobilization quantification
Avidin has a maximum absorption at a wavelength of
230 nm, which was determined by a scanning spectrum.
Therefore, a UV spectrometer (Biotek, Winooski, VT, USA)
was used to evaluate the total amount of avidin conjuga-
tion. After avidin conjugated with glutaraldehyde on the
material surface, 150 µl of supernatant was transferred to
UV-penetrateable 96-microwell plates (Coring). Standard
avidin solutions with different concentrations were used
for comparison. The immobilized avidin was determined
by subtracting the supernatant avidin values from the
total amount of avidin present before the reaction.
Biotin-AP immobilization assay
Biotin-AP was used to simulate small biotinylated
molecule binding profiles by two different avidin
immobilization strategies. The surface biotin binding sites
of the VBAM and VBABM systems were analysed by
using different concentrations of biotin-AP. After 1 h of
incubation, unbound biotin-AP was removed by washing
with PBS. Finally, the PNPP substrate was developed for
5 min and absorbance was read at OD405.
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Virus immobilization and sandwich
ELISA assay
The biotinylated AdLacZ was immobilized on the material
surface by two strategies, the VBAM system and the
VBABM system. After avidin immobilization, biotinylated
virus was incubated on the chitosan surfaces for 2 h at
4 ◦C, and was then washed with PBS to remove unbound
virus.
The immobilized virus was labelled with rabbit
anti-adenovirus antibody (Abcam) followed by anti-
rabbit immunoglobulin G antibody conjugated alkaline
phosphatase (Abcam) for 1 h each. Finally, PNPP
substrate was added to quantify the surface immobilized
virus.
Heterogeneity evaluation by Sips
isotherm adsorption model
Sips isotherm adsorption is a modified model from the




where I is the intensity of adsorption that can be
the optical density of the substrate PNPP (OD405) in
this study, Isat is the intensity during saturation, C is
the concentration of biotinylated molecules, b is the
affinity of biotinylated molecules towards avidin, and
a is the heterogeneity index, which is the exponent of the




Isat − I ) = a ln b + a ln C
The heterogeneity index, a, and the affinity factor, b, can
be determined by plotting ln(I/(Isat − I)) to ln C. The slope
of the least-squares regression line would be a and the
intercept would be a ln b.
Most often, the association constant between proteins
and ligands follows a Gaussian distribution. Heterogeneity
is used to describe the deviation of the association
constant distribution when the protein is immobilized
on a solid substrate. Because the associate and dissociate
behaviour between immobilized proteins and their ligands
deviates from when they are in solution, this deviation is
always accompanied by a higher heterogeneity. The non-
uniform binding affinity distribution can be evaluated
by the heterogeneity index, a, which should be between
0 and 1. When a = 1, the affinity of an immobilized
protein to ligands is the same as it is in solution, and
a lower value a indicates an increasing heterogeneity.
Therefore, by a heterogeneity index comparison, we
could evaluate the level of immobilized protein affected
by the conjugation reaction. Lower affinity constants
and heterogeneity indexes indicate that immobilization
introduces heterogeneity into the binding behaviour and
thus diminishes ligand binding activity [25].
Scanning electron microscopy (SEM)
illustrates virus immobilization
on chitosan surfaces
Chitosan surfaces with immobilized AdLacZ by the VBAM
and VBABM methods were washed with PBS to remove
unbound adenovirus and fixed with 10% glutaraldehyde
in PBS for 1 h. Subsequently, these samples were postfixed
in 1% osmium tetroxide (Acros) for 1 h. After two washes
with distilled water, the samples were incubated at −80 ◦C
for 2 h and then lyophilized in a freeze dryer (Virtis,
Gardiner, NY, USA) at −78.51 ◦C and 100 mTorr for
24 h. Samples were gold coated (SPI, West Chester, PA,
USA) and examined by SEM (Nova Dual Beam FIB/SEM;
FEI, Hillsboro, OR, USA).
In vitro cell infection to determine
viral activity
Cell infection was performed to determine the cell
transduction efficiency of the immobilized virus. The
fibroblast cell line C4 was cultured at a density of 2 ×
105 cells/well in 24-well culture plates coated by chitosan.
Four different systems were compared: (i) VBAM; (ii)
VBABM; (iii) a system in which the cells were seeded on
one day and then infected by suspend virus (Free V); and
(iv) a system in which both virus and cells were mixed
and then seeded into the wells (Free V & Cell).
To determine the exact amount of viral particles
immobilized on chitosan surfaces in the VBAM and
VABAM systems, a sandwich ELISA was performed.
After the virus was immobilized on the material surface,
100 µl of supernatant was applied to goat anti-adenovirus
antibody coated 96-microwell plates for 1 hour. The
bound virus was labelled by first and second antibody,
and then was detected by substrate PNPP, as previously
described in the virus immobilization experiment. Finally,
the amount of immobilized virus was determined by
subtracting the supernatant virus from the total amount
of virus present before the reaction.
For cell infections, C4 fibroblasts were infected with
a range of virus concentrations (0–1.6 × 109 pfu/well)
and were cultured for 48 h. The transduction efficien-
cies of each group were determined by the expression
of β-galactosidase, which was detected using a sand-
wich ELISA kit, as previously described. The data were
normalized to the amount of surface viral particles. Addi-
tionally, transduced cells were illustrated by staining with
5-bromo-4-chloro-3-indoyl-β-D-galactopyranoside (X-gal)
[10].
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Results
Adenovirus biotinylation does not alter
viral bioactivity
Biotinylation of virus by SulfoNHS-LC-Biotin has been
reported to preserve the infectivity of the virus [23].
Therefore, to maximize the level of biotinylation of
adenovirus, a sandwich ELISA was used to quantify
adenoviral surface biotinylation. Viral biotinylation was
saturated when the concentration of SulfoNHS-LC-Biotin
exceeded 0.5 mg per 1012 viral particles (Figure 1a).
The HABA assay of biotinylated virus demonstrated
that there were 6209 ± 505 biotin molecules per viral
particle. This high level of biotinylation suggests that
virus can be robustly immobilized on chitosan. The
viral infection efficiencies of adenovirus before and
after biotinylation were also compared by infecting C4
fibroblasts. β-galactosidase expression by infected cells
was quantified by ELISA (Figure 1b). The expression of
biotinylated AdLacZ was in the range 80–90% in the non-
modified virus group, suggesting that virus infectivity can
be preserved after biotinylation.
Avidin/biotin crosslinked
by homobifunctional crosslinker
have different binding effects
Two different strategies for avidin immobilization to chi-
tosan were developed to tether viruses for in situ gene
therapy. Avidin was either directly conjugated to a mate-
rial surface (VBAM) or indirectly docked on surface
conjugated biotin (VBABM). To optimize the crosslinker
concentration of these two immobilization strategies,
avidin and biotin were conjugated to chitosan surfaces
with different concentrations of the homobifunctional glu-
taraldehyde crosslinker. These conjugates were analysed
using biotin-AP and avidin-AP, respectively (Figures 2a
and 2b). The avidin and biotin conjugation profiles dif-
fered significantly. Avidin conjugation increased with
glutaraldehyde concentration and was saturated at 0.75%
glutaraldehyde; however, a sharp decline in conjugation
occurred with glutaraldehyde levels greater than 7.5%
(Figure 2a). Biotin conjugation followed a different trend
than avidin. The surface biotin, when in a system with
increasing crosslinker, eventually reached a plateau at
approximately 7.5% glutaraldehyde (Figure 2b). How-
ever, there was no decrease in conjugation at the highest
concentration of crosslinker as was observed with avidin
conjugation. Despite finding that 0.75% and 7.5% glu-
taraldehyde have the best conjugation rates for avidin
and biotin, respectively, these high levels of glutaralde-
hyde may be harmful to cells. Therefore, to avoid potential
cytotoxicity, 0.25% glutaraldehyde was applied for the
following experiments because this level was effective for
crosslinking and yet was nontoxic to cells in culture (data
not shown).
Figure 1. Adenovirus encoding LacZ can be biotinylated by
SulfoNHS-LC-Biotin. (a) Biotinylated virus was immobilized on
ELISA plates to detect and quantify biotin on viral surfaces using
avidin-AP. The data suggest that biotinylation is dose-dependent
and saturated when SulfoNHS-LC-Biotin is greater than 0.5 mg
per 1012 viral particles. (b) The β-galactosidase expression
from cells infected by AdLacZ before (solid line) and after
(dashed line) biotinylation were compared by sandwich ELISA.
The results demonstrate that AdLacZ can maintain infection
efficiency in the range 80–90% after biotinylation
Because high crosslinker concentrations led to a
decrease in direct avidin conjugation, there may have
been other factors affecting the crosslinking between
avidin and material surfaces. To investigate this, avidin
was conjugated to chitosan with different concentrations,
in the range 1–250 µg/well. Two experiments were
performed to determine the amount of immobilized avidin
molecules and the biotin binding sites, respectively. The
avidin in the supernatant after the conjugation reaction
was detected by UV spectrometry to indirectly quantify
the immobilized avidin molecules on the material surface
(Figure 3a). At the same time, the effective surface biotin
binding sites on chitosan were directly determined with
biotin-AP (Figure 3b).
From the UV detection assay, the immobilized avidin
molecules on the chitosan surface increased with
increasing concentrations of avidin. The conjugation
efficiency was approximately 6.8% (Figure 3a). By
contrast, when directly detecting surface binding sites on
chitosan, high avidin concentrations increased biotin-AP
immobilization; however, this trend plateaued with avidin
concentrations greater than 30 µg/well (Figure 3b).
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Figure 2. The conjugation profiles of homobifunctional
crosslinker in the VBAM and VBABM systems are different. (a) In
the VBAM system, avidin immobilized on chitosan increased with
increasing concentrations of the crosslinker. However, extremely
high crosslinker concentration led to a decrease in surface immo-
bilization. (b) Because biotin conjugation by Amine-PEO3-Biotin
can avoid self-crosslinking due to a single reactive amine group,
the conjugation remained strong at saturation levels even in
high crosslinker concentrations
Comparison of VBAM and VBABM
immobilization strategies
To demonstrate differences in biotin immobilization
efficiency between the VBAM and VBABM systems,
biotin-AP and biotinylated adenovirus were compared
(Figures 4a and 4b). Biotin-AP is a small protein whereas
biotinylated adenovirus is a large complex, and thus they
can be used to compare different immobilization effects
for small and large biotinylated molecules. The surface
immobilized avidin (30 µg/well) was used in both groups
according to the saturation concentration from the prior
titration experiment.
Results of the biotin-AP assay demonstrated that
immobilization in both systems increased with biotin-
AP concentration (Figure 4a). To investigate the affinities
of surface avidin to biotinylated molecules in these two
systems, we referred to the Sips isotherm adsorption
model because it is an association-dissociation assessment
for antibody-antigen that is similar to biotin–avidin
interaction [25,26]. The binding data were fitted into
the Sips isotherm adsorption equation and the fitting
Figure 3. Avidin is conjugated on chiotsan as a multilayer.
(a) Immobilized avidin molecules were evaluated by indirectly
detecting unbound avidin suspended after conjugation. Immo-
bilized avidin increased with increasing avidin concentration.
(b) By contrast, biotin-AP analysis suggested that the surface
binding sites reached a plateau when avidin concentrations
were greater than 0.03 mg/well, which is due to limited chi-
tosan surfaces. The inconsistent trends suggest that a multilayer
of avidin formed on the chitosan surface
parameters are summarized in Table 1. The heterogeneity
index, a, of VBABM was 1.000, suggesting that the
interaction between immobilized avidin and biotin-
AP was homogeneous. That is, the affinity of surface
avidin for biotin-AP was similar to the affinity of
avidin for biotin in solution. By contrast, the directly
bound avidin in the VBAM system exhibited some
heterogeneity (a = 0.894). The loading capacity in the
VBABM system was also higher than in the VBAM
system. The saturation intensities of bound alkaline
phosphatase were 4.2 and 3.0 for VBABM and VBAM,
respectively. Therefore, the lower heterogeneity index
suggests that surface immobilization of the VBAM
system induced heterogeneity between biotin-AP and
avidin, whereas the VBABM system did not. This also
suggests a diminished binding activity of the VBAM
system.
For biotinylated virus immobilization, the trends of
heterogeneity were more pronounced than those of
biotinylated-AP for both the VBAM and VBABM methods
(Figure 4b). The heterogeneity index of the VBAM system
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Figure 4. Biotinylated molecule immobilization of the VBABM
system is greater than that of the VBAM system. Two different
biotinylated molecules were applied and the binding capacities
were compared: (a) biotin-AP and (b) biotinylated AdLacZ. The
dashed and solid lines represent the Sips model fits of the data
of VBABM (triangle) and VBAM (square) systems, respectively
(a = 0.540) was less than the VBABM system (a = 0.832).
The saturation intensity of VBAM (Isat = 0.33) was
also lower than VBABM (Isat = 0.56). Moreover, the
binding affinity of VBABM was almost double that
of VBAM (0.269 ml/109 VP versus 0.135 ml/109 VP)
(Table 1). The lower heterogeneity indexes of both
the VBAM and VBABM systems indicate that large
biotinylated molecules, such as adenoviruses, may be
more sensitive to steric hindrance than smaller molecules.
This phenomenon of higher heterogeneity would affect
the interaction between ligand (biotin) and receptor
(avidin), and thus the adsorption behaviour would
diverge from their homogeneous interaction in solution
form.
Immobilized virus distribution was
examined by SEM
SEM examination was performed to illustrate the surface
virus distribution. In the VBAM system, virus clusters were
found in low magnification (Figure 5a). These clusters
were formed by uniform size particles, which were more
obvious in high magnification. Compared to the typical
sizes of adenovirus (70–90 nm), these particles, with
diameter in the range 70–80 nm, suggest that they are
adenoviruses immobilized on chitosan surfaces [27].
Similarly, the VBABM system had viral particles the
same size as those in the VBAM system. However, the
distribution was different (Figure 5b). Evenly distributed
particles without clusters were observed in this group.
Moreover, the number of adenoviral particles bound in the
VBABM group per unit area was obviously higher than in
the VBAM group. These results suggest that biotinylated
adenovirus can be more effectively immobilized by the
VBABM method due to surface avidin alignment.
VBABM system has an improved cell
transduction efficiency over the VBAM
system
Adenovirus encoding the LacZ gene (AdLacZ) was used
to transduce C4 fibroblasts to compare viral infection
efficiencies of two immobilization strategies. The cells
were infected and incubated for two days, followed by
an ELISA assay to quantify β-galactosidase expression
levels (Figure 6a). The adherent cells infected with free
virus (Free V) had the lowest transduction rate. This
rate was improved when cells were infected with virus
in a suspended solution (Free V & Cells) because the
virus likely contacted cells in a homogeneous medium
rather than in a potentially heterogeneous liquid-solid
environment. Virus immobilized by the VBAM system was
not superior because it had a similar infection profile
to the Free V group. However, VBABM exhibited a
significantly higher transduction efficiency. Moreover, the
β-galactosidase activity at saturation in the VBABM group
was 3 µg/well compared to 2 µg/well in the Free V and
VBAM group and 2.5 µg/well in the Free V & Cell group.
These findings suggest that biotin on biomaterial surfaces
can increase the effective binding sites for biotinylated
virus immobilization and thus enhance the transduction
efficiency. The X-gal staining also illustrated that cells
cultured on plates can be infected by VBAM and VBABM
Table 1. Fitting parameters for the Sips isotherm adsorption model
Biotin-AP Biotinylated AdLacZ
VBAM VBABM VBAM VBABM
Saturation intensity, Isat 3.0 4.2 0.33 0.56
Heterogeneity index, a 0.894 1.000 0.540 0.832
Binding affinity b 14.1 ml/pg 15.9 ml/pg 0.135 ml/109 VP 0.269 ml/109 VP
VP, Viral particles.
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Figure 5. SEM images illustrate virus immobilization in both VBAM and VBABM systems. Adenovirus immobilized on chitosan
surfaces was demonstrated by SEM examination. The chitosan surface images of (a) VBAM and (b) VBABM groups are shown with
different magnifications. The scale bars under each picture are 1 µm. Viral particles tended to form aggregates or clusters in the
VBAM system, whereas the VBABM system led to evenly distributed viral particles
systems and the β-galactosidase expression levels were
consistent to their ELISA results (Figure 7).
The levels of virus in the VBAM and VBABM systems are
likely underestimated because immobilized virus was not
totally bound on the chitosan surfaces. Excess virus was
removed by PBS washes prior to cell infection. The true
amounts of immobilized virus were indirectly detected
by quantifying unbound virus using a sandwich ELISA
assay. In the VBABM group, 95–100% of adenovirus
can be immobilized on surfaces when there are less
than 1 × 108 viral particles per well. Higher virus
concentration caused the immobilization rate to decline
due to limited substrate area. In contrast, VBAM had only
a 40–60% immobilization rate in the same concentration.
Therefore, we normalized the cell transduction results
to the immobilized virus levels. This normalization
demonstrated better performances in both VBAM and
VBABM systems. The result of the VBAM group was similar
to the Free V & Cell group, whereas the VBABM group had
a much better performance than the other three groups
(Figure 6b). β-galactosidase expression of VBABM was
saturated when there were 4 × 107 pfu AdLacZ, which
was almost six, ten and 50-fold greater than that of the
VBAM, Free V & Cell, and Free V groups, respectively,
when using the same virus concentrations.
Discussion
The method of virus delivery can have a profound
influence on the outcomes of regenerative gene therapy.
While bolus delivery requires high viral titers and provides
little control over virus diffusion, spatially controlled
viral infection may restrict viral transduction to only
the target sites and limit systemic infection. Virus
localization can also improve transduction efficiency,
and thus the viral dosage may be reduced [10,28,29].
These effects can decrease potential risks and increase
therapeutic safety. In this study, virus immobilization
was performed by avidin/biotin interaction, the strongest
known noncovalent bond, which should be able to
tightly tether virus on material surfaces [20]. However,
some research indicates that the cell transduction of
biotinylated adenovirus tethered on avidin coated plates
for in situ transduction is modest in comparison to
free infection delivery [23]. This may be due to steric
hindrance of active binding sites, that can be inactivated
when they are close to the solid support surface [30].
In addition, the microenvironment of the surface and
the potential conformational changes of immobilized
proteins can lead to heterogeneous binding affinity and
association/dissociation kinetics to their complementary
ligands [31–33]. Therefore, determining how to reduce
the heterogeneity of the binding force and how to preserve
protein function are important issues for protein surface
immobilization.
To reduce heterogeneity, orientated immobilization is
an improved strategy because it can reduce the blockage of
binding sites. For example, to orientate immunoglobulin
G on support surfaces for immunosorption, the Fc
regions are used for immobilization on solid supports
by either conjugating with its carbohydrate residues or
by mediating protein A/G conjugation [34–36]. These
strategies allow the Fab regions to be exposed and thus
avoid steric hindrance due to random conjugation. These
data suggest that orientated immobilization can reduce
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Figure 6. In vitro cell transduction demonstrates the infection
efficiency of the immobilized virus. (a) Virus was immobilized
by the VBAM (triangle) or VBABM (cross) methods on 24-well
culture plates and then cultured with 2 × 105 cells/well. There
were two control groups using suspended virus infection:
(1) cells were plated for 24 h prior to infection in solution
(Free V, square) and (2) cells and virus were mixed together
before the cells were plated (Free V & Cell, diamond). (b) The
viral particles on chitosan surfaces were indirectly estimated by
detecting unbound virus after immobilization. This reflects the
real surface virus number and normalizes the virus infection
result
heterogeneity and enhance receptor-ligand adsorption.
By a similar hypothesis, one can assume that biotinylated
virus immobilized on material surfaces can be orientated
in the VBABM system because the immobilized avidin can
be aligned by the surface conjugated biotin (Figure 8b).
This differs from the randomly distributed avidin in the
VBAM system due to nonspecific conjugation (Figure 8a).
In the present study, we used biotinylated reagent to
modify viral capsid proteins. Compared to other research,
that genetically fuses a biotin acceptor peptide to a virus
and then biotinylates the virus later, our method is easier
and can be applied more generally for different viral
vectors [22]. The infectivity of biotinylated adenovirus can
be maintained at 80–90%, suggesting that SulfoNHS-LC-
Biotin is mild and appropriate for adenovirus modification
(Figure 1b).
Conjugation with various crosslinker concentrations
demonstrated different profiles of these two methods
(Figures 2a and 2b). In the VBAM system, avidin was
directly bound to the surface by glutaraldehyde, a
homobifunctional crosslinker that randomly conjugates
with amines to form Schiff bonds [37]. This conjugation
not only links avidin to chitosan, but also to different
avidins. Higher concentrations of glutaraldehyde can
increase the crosslinking and thus immobilize more avidin
on the material surface (Figure 2a). Saturation occurs due
to the default area of chitosan coated on the wells. The
amount of avidin may be increased with layering, but
the total binding sites for biotin should be consistent.
However, a concentration of crosslinker molecules that is
too high may cause avidin conjugation to be distributed
unevenly on the material surface. The increasing
roughness may cause steric hindrance and thus decrease
biotin immobilization. The multilayer property of the
VBAM system was demonstrated by using different avidin
concentrations to compare the relationship between
surface avidin (UV detection) and potential binding sites
(biotin-AP assay) (Figures 3a and 3b). The binding sites
were increased with avidin concentration, and were
saturated when avidin was greater than 30 µg/well.
By contrast, immobilized avidin kept rising even when
the avidin concentration was more than 30 µg/well.
These results suggest that immobilization increases
with increasing avidin concentrations during conjugation
because of inter-avidin crosslinking, whereas the binding
sites were limited due to the default area of the coated
chitosan. Conversely, in the VBABM system, because
the Amine-PEO3-Biotin has only one functional end for
conjugation, multilayer formation such as in the VBAM
system may not occur in this condition (Figure 2b).
Because avidin conjugation is nonspecific, biotin
binding was likely affected to a certain extent by
immobilization. Direct conjugation may inactivate some
biotin binding sites on avidin. In addition, if the
binding regions are close to the solid phase material
or hindered by other avidin molecules, the affinity
could be reduced because of steric blockage effects.
To evaluate the effects of steric hindrance on affinities
for different sized biotinylated molecules, biotin-AP and
biotinylated AdLacZ were immobilized by surface avidin
through the VBAM or VBABM methods. Binding affinity
assessment was achieved by the heterogeneity index
evaluation from the Sips isotherm adsorption model
[25,26]. The saturation intensities for both biotin-AP and
biotinylated AdLacZ indicated that the VBABM system had
higher adsorption levels than VBAM (Figures 4a and 4b).
Judging by Sips isotherm equations, VBABM expressed
nearly homogeneous adsorption to biotin-AP. Even for
large biotinylated molecules such as the biotinylated
AdLacZ, the heterogeneity index of VBABM was closer
to 1 than in the VBAM system (Table 1). This suggests
that orientated avidin can enhance biotinylated molecule
immobilization and reduce heterogeneity.
SEM illustrated that adenovirus was immobilized on
material surfaces in both VBAM and VBABM groups
because there were abundant uniformly sized particles
on chitosan with diameters in the range 70–80 nm,
consistent with the typical diameters of adenovirus in
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Figure 7. X-gal staining demonstrates β-galactosidase activity in infected cells using the four infection models and a range of
viral particles (1 × 108 to 16 × 108 pfu). Darkly stained cells represent β-galactosidase expression in transduced cells. The VBABM
system performed much better than the other groups and had maximal activity with as little as 1 × 108 pfu
Figure 8. Schematic models of the two virus immobilization systems developed in the present study. (a) Virus–biotin–avidin-material
(VBAM) system. (b) Virus–biotin–avidin–biotin-material (VBABM) system
the range 70–90 nm (Figures 5a and 5b). There were
many aggregates of the adenovirus shown in the VBAM
group, which is likely due to the unevenly distributed
biotin binding sites (Figure 5a). In the VBAM method,
random avidin conjugation may cause different avidin
molecules to connect to each other. This inter-avidin
crosslinking could lead to avidin being immobilized
on the chitosan surface as clusters. By contrast,
the VBABM system could avoid this drawback and,
consequently, evenly distribute adenovirus on chitosan
surfaces (Figure 5b).
In assessing in vitro cell transduction, the virus immobi-
lized by the VBAM method demonstrated modest infection
efficiency compared to the excellent transduction in the
VBABM method. To fairly evaluate virus dosage in the
VBAM and VBABM groups, suspended viral particles after
conjugation were detected for normalization. The infec-
tion of VBAM was comparable to the Free V & Cell group
and was better than the Free V group after normaliza-
tion (Figure 6b). Interestingly, VBAM still had a lower
transduction efficiency than VBABM, even with the same
number of immobilized viral particles. This may be due
to the virus biotinylation reagent, SulfoNHS-LC-Biotin,
which has a spacer between biotin and the viral protein.
Because avidin immobilized by random conjugation may
increase surface roughness and result in unevenly dis-
tributed binding sites, the spacer may be entangled when
biotin is bound to the surface. This may inhibit a viral
particle from being internalized into cells and thus reduce
infection. Therefore, the orientated biotin immobilization
in the VBABM strategy not only increases effective bind-
ing sites for biotinylated virus immobilization, but also
improves virus infection efficiency.
Consequently, in the present study, a new method
was developed to immobilize adenovirus on biomaterial
surfaces for in situ gene therapy. Chitosan surfaces can be
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modified and used as an efficient viral carrier. In addition,
adenovirus biotinylation can modify viral surfaces while
preserving its infectivity. The VBABM model can evenly
tether adenovirus on a chitosan surface, and can improve
virus transduction. Excessive viral titer, which may induce
cytotoxicity and unwanted systemic infection, may be
avoided with this system. This model of viral delivery
could be adapted for use with not only a variety of
biomaterials, but also different types of viral vectors and
thus may be an alternative method for in vivo regenerative
gene therapy.
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